117 related articles for article (PubMed ID: 11719969)
1. Response to pulsed dose rate irradiation with and without mild hyperthermia using tumour and normal cell lines.
Niedbala M; Ng CE; Raaphorst GP
Int J Hyperthermia; 2001; 17(6):536-44. PubMed ID: 11719969
[TBL] [Abstract][Full Text] [Related]
2. Equivalence of pulsed-dose-rate to low-dose-rate irradiation in tumor and normal cell lines.
Niedbala M; Alsbeih G; Ng CE; Raaphorst GP
Radiat Res; 2001 Feb; 155(2):297-303. PubMed ID: 11175664
[TBL] [Abstract][Full Text] [Related]
3. Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin.
Raaphorst GP; Maio J; Ng CE; Stewart DJ
Oncol Rep; 1998; 5(4):971-7. PubMed ID: 9625857
[TBL] [Abstract][Full Text] [Related]
4. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1998; 41(6):491-6. PubMed ID: 9554594
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Ng CE
Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cisplatin treatment given concurrently with pulsed irradiation in cisplatin sensitive and resistant human ovarian carcinoma cell lines.
Leblanc JM; Raaphorst P
Int J Radiat Biol; 2005 Jun; 81(6):429-35. PubMed ID: 16308913
[TBL] [Abstract][Full Text] [Related]
7. Effect of simultaneous pulsed hyperthermia and pulsed radiation treatment on survival of SiHa cells.
Kim CS; Hill RP; Kumaradas JC; Irvine R; Liu FF; Sherar MD
Int J Hyperthermia; 1998; 14(6):573-81. PubMed ID: 9886663
[TBL] [Abstract][Full Text] [Related]
8. Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment.
Raaphorst GP; Chabot P; Doja S; Wilkins D; Stewart D; Ng CE
Int J Hyperthermia; 1996; 12(2):211-22. PubMed ID: 8926390
[TBL] [Abstract][Full Text] [Related]
9. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Wang G; Stewart D; Ng CE
Int J Radiat Biol; 1996 May; 69(5):623-31. PubMed ID: 8648250
[TBL] [Abstract][Full Text] [Related]
10. Equivalence of continuous and pulse simulated low dose rate irradiation in 9L gliosarcoma cells at 37 degrees and 41 degrees C.
Armour E; Wang ZH; Corry P; Martinez A
Int J Radiat Oncol Biol Phys; 1992; 22(1):109-14. PubMed ID: 1727106
[TBL] [Abstract][Full Text] [Related]
11. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Doja S; Davis L; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1996; 37(6):574-80. PubMed ID: 8612312
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines.
van de Vaart PJ; van der Vange N; Zoetmulder FA; van Goethem AR; van Tellingen O; ten Bokkel Huinink WW; Beijnen JH; Bartelink H; Begg AC
Eur J Cancer; 1998 Jan; 34(1):148-54. PubMed ID: 9624250
[TBL] [Abstract][Full Text] [Related]
13. Response to pulsed dose rate and low dose rate irradiation with and without mild hyperthermia using human breast carcinoma cell lines.
Niedbala M; McNamee JP; Raaphorst GP
Int J Hyperthermia; 2006 Feb; 22(1):61-75. PubMed ID: 16423753
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of hyperthermia at 42 degrees C and irradiation dose of 2 Gy on two rat yolk sac tumor cell lines with different radio-thermosensitivity in vitro.
Tamaki Y; Mitsuhashi N; Sakurai H; Islam MS; Takahashi T; Akimoto T; Ishikawa H; Saitoh J; Muramatsu H; Niibe H
Anticancer Res; 2002; 22(6A):3143-8. PubMed ID: 12530057
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin.
Raaphorst GP; Mao J; Yang H; Goel R; Niknafs B; Shirazi FH; Yazdi HM; Rippstein P; Ng CE
Anticancer Res; 1998; 18(4C):2945-51. PubMed ID: 9713489
[TBL] [Abstract][Full Text] [Related]
16. Thermal radiosensitization by 41 degrees C hyperthermia during low dose-rate irradiation in human normal and tumour cell lines.
Raaphorst GP; Heller DP; Bussey A; Ng CE
Int J Hyperthermia; 1994; 10(2):263-70. PubMed ID: 8064184
[TBL] [Abstract][Full Text] [Related]
17. Elimination of dose-rate effects by mild hyperthermia.
Wang Z; Armour EP; Corry PM; Martinez A
Int J Radiat Oncol Biol Phys; 1992; 24(5):965-73. PubMed ID: 1447038
[TBL] [Abstract][Full Text] [Related]
18. [In vitro studies of PDR brachytherapy].
Fritz P; Frank C; Weber KJ
Strahlenther Onkol; 1998 Jul; 174(7):365-74. PubMed ID: 9689958
[TBL] [Abstract][Full Text] [Related]
19. Radiation enhanced efficiency of combined electromagnetic hyperthermia and chemotherapy of lung carcinoma using cisplatin functionalized magnetic nanoparticles.
Babincová M; Kontrisova K; Durdík S; Bergemann C; Sourivong P
Pharmazie; 2014 Feb; 69(2):128-31. PubMed ID: 24640602
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic enhancement of high dose-rate irradiation in 9L gliosarcoma cells.
Armour EP; Wang Z; Corry PM; Chen PY; Martinez A
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):171-7. PubMed ID: 8270439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
